Takeover target Allergan Inc., the company that makes Botox, has adopted a "poison pill" defense intended to delay a buyout by Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman.
Stocks snapped their recent winning streak Wednesday, as weakness in technology shares weighed on equity indexes. The Dow Jones Industrial Average shed 12.72 points, or 0.1%, to 16501.65.
Demand from homebuyers continues to outpace supply, according to new housing numbers released yesterday, and experts said relief from rising prices and low inventory isn't in sight anytime soon.
SYDNEY/SINGAPORE (Reuters) - The New Zealand dollar rallied on Thursday after the country's central bank raised interest rates and signaled more hikes ahead, while caution ahead of a speech by the European Central Bank's president kept the euro ...
... * Q1 net profit $2.97 bln vs $2.7 bln in Reuters poll. * Sales at $14 bln vs forecast for $14.25 bln forecast. * Confirms full-year outlook (Adds further earnings figures, restructuring).